NNNN
Anbio BiotechnologyยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NNNN Profile
Anbio Biotechnology
A globally leading medical device and reagent company
Biological Technology
07/27/2021
02/19/2025
NASDAQ Stock Exchange
27
12-31
Common stock
Wilhelm Gutbrod Str 21B, 60437, Frankfurt am Main, Germany
--
Anbio Biotechnology was incorporated in the Cayman Islands on July 27, 2021. The company is committed to the advancement of medical technology and the provision of in vitro diagnostic products. Their unwavering commitment is to transform the diagnostic landscape on a global scale, facilitating a paradigm shift towards personalized and decentralized diagnostic solutions.
